# Signal — Asset Package | Executive Summary

**STTIL Solutions LLC | Confidential | April 2026**

---

## Market Opportunity

The CGM DMEPOS market is entering a window of structural stress that rewards
suppliers with proactive coverage management tooling.

- **2028 Competitive Bidding (CB):** CMS is expanding CB to CGM categories.
  Margin compression will accelerate. Suppliers that reduce denials and appeals
  overhead gain a direct cost advantage over competitors still running manual,
  reactive workflows.
- **Prior Authorization Expansion (April 13, 2026):** CMS implemented expanded
  PA requirements for CGM and related DMEPOS categories. Every prior auth cycle
  introduces a coverage gap risk. Suppliers need automated visibility into
  those gaps to act before a claim touches a PA trigger.
- **Enrollment Moratorium:** CMS supplier enrollment moratoria in high-risk
  areas are tightening the supply pool. Existing enrolled suppliers face
  consolidation pressure and rising per-patient management burden — exactly
  the problem Signal is designed to reduce.
- **Denial Patterns:** CGM claims deny on predictable, preventable conditions:
  coverage lapsed before refill, physician visit not renewed on the Medicare
  180-day cycle, quantity exceeds allowable without documentation. Signal
  flags all three before shipment, not after.

The total addressable market is approximately 7,500 Medicare-enrolled DMEPOS
suppliers billing CGM. A conservative 1% penetration at $3,600 ARR = $2.7M ARR.
CMS projects CGM beneficiaries to exceed 3.2 million by 2028.

---

## What Signal Does

Signal is a B2B coverage worklist tool built for DMEPOS supplier back-office
teams. It replaces manual spreadsheet tracking with an automated, rule-driven
coverage clock.

- **Coverage Clock:** Calculates coverage expiration per patient per device
  using payer-specific wear-day rules (Dexcom G6/G7, Libre 2/3, Omnipod 5).
  Medicare visit renewal (180 days) is tracked as a separate flag.
- **24-Hour Batch Worklist:** n8n orchestration runs nightly. Staff arrive to a
  sorted worklist — `OUT_OF_COVERAGE`, `VISIT_DUE`, `REFILL_WINDOW`, `OK` —
  with highest-urgency patients at the top.
- **Minimal PHI Surface:** The system ingests `patient_id`, `device_type`,
  `shipment_date`, `quantity`, `payer` only. No names, SSNs, DOBs, or contact
  information enter the system. The supplier's own staff map `patient_id` back
  to identity in their existing systems (Brightree, EHR). All audit logs hash
  identifiers before storage.
- **Self-Hosted:** Runs on supplier's own VPS or STTIL-managed Hostinger VPS.
  Data never leaves the supplier's network. No third-party SaaS dependency
  on the data path.

---

## What's Included in the Sale

| Asset | Description |
|-------|-------------|
| Full source code | Python/FastAPI backend, coverage calculator, audit logger, PostgreSQL models, payer rules config |
| Research library | DMEPOS market research v3, compliance roadmap v1, CB/PA regulatory analysis |
| BAA templates | Hostinger VPS BAA request template; operator BAA framework for customer agreements |
| Newsletter strategy | Subscriber acquisition strategy for DMEPOS supplier outreach (v1) |
| n8n workflows | Self-hosted batch trigger workflow exports |
| `CLAUDE.md` handoff | Full AI-assisted development context file — new owner can continue building with Claude Code with zero ramp-up loss |
| 30-day knowledge transfer | Live sessions with STTIL Solutions founder covering architecture, payer rule updates, compliance posture, and go-to-market |

Buyer receives all intellectual property, documentation, and development context
as a clean, working asset. No vendor lock-in. No ongoing royalty.

---

## Ideal Buyer Profile

**Option A — DMEPOS Supplier (Direct User)**
A mid-size supplier billing 200–2,000 CGM patients/month who currently manages
coverage tracking in spreadsheets or Brightree custom fields. Immediate ROI
through denial reduction. Can deploy internally or white-label for peer suppliers.

**Option B — Healthcare Operator / DME Platform**
A DMEPOS software vendor, billing company, or managed services operator looking
to add a differentiated coverage intelligence module to their existing platform.
Signal integrates cleanly into existing FastAPI or Django stacks.

**Option C — Consortium or Buying Group**
A DMEPOS buying group or GPO representing multiple suppliers. Acquire once,
deploy across member base. License to members as a value-add service. Buying
groups operating in markets with active CB expansion have the strongest urgency
case.

---

## Investment Range

**$25,000 — $60,000** (one-time asset acquisition)

Range reflects buyer type and included transfer scope. Direct supplier buyers
at the lower end. Platform/operator buyers and consortium structures at the
higher end. All terms negotiated directly with STTIL Solutions LLC.

No SaaS subscription required. No ongoing royalty. Buyer owns the asset outright.

---

## Why Now

- PA expansion is live as of April 13, 2026 — suppliers are feeling it now
- CB 2028 planning cycles begin at the supplier level 18–24 months out
- The enrollment moratorium is reducing the number of new entrants who can
  absorb this problem with headcount — existing suppliers must solve it with tools
- Early buyer gets the asset before it is offered to competitors in their market
- 30-day knowledge transfer window is time-limited and not guaranteed after
  initial close

---

## Contact

[CONTACT PLACEHOLDER]